This decision to reposess my policy might make the board meeting agenda item moot. Alcor won't have to hand onto my policy.
As for the amount... we can see in Alcor's own articles that the policy for providing for inflation and tech increases has been inconsistent (insane?)...
I should also note that in 1982, when the current minimums were set, a generous allowance was made for anticipated increases in the cost of perfusion and cooling to liquid nitrogen temperature. Such increases were anticipated to be in the areas of labor, inflation, and technological upgrades. Providing such a "safety factor" has proved very wise, allowing us to do as well as we have. The new suspension funding minimums proposed above do not reflect such an allowance for future increases in the cost of perfusion and cooling. It seems likely that labor costs will continue to increase disproportionately and that inflation also will continue to be a significant cause of cost increase. Thus, it would be prudent to consider providing for future cost increases when examining a potential increase in suspension funding minimums.